✦ LIBER ✦

Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients

✍ Scribed by Ling Xu, HeGen Li, ZhenYe Xu, ZhongQi Wang, LingShuang Liu, JianHui Tian, JianLi Sun, Lei Zhou, YiLin Yao, LiJing Jiao, Wan Su, HuiRu Guo, PeiQi Chen, JiaXiang Liu

Book ID: 119899356
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 187 KB
Volume: 12
Category: Article
ISSN: 1472-6882
DOI: 10.1186/1472-6882-12-112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy in conjunction with traditi

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial

✍ Zhou, Zhi-yi; Xu, Ling; Li, He-gen; Tian, Jian-hui; Jiao, Li-jing; You, Sheng-fu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 648 KB

Clinical study on treatment of non-small

Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy

✍ Cheng-lin Liu; Yuan-dong Wang; Yuan-dong Jin; Li-ping Liu; Qing-wei Yu; Yu-cheng 📂 Article 📅 2001 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 470 KB

Effect of Astragalus injection combined

Effect of Astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer

✍ Zou Yu-he; Liu Xue-mei 📂 Article 📅 2003 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 97 KB

Effect of TCM combined with chemotherapy

Effect of TCM combined with chemotherapy on immune function and quality of life of patients with non-small cell lung cancer in stage III-IV

✍ Yang Zu-yi; Wu Xue-mei; Ou Ya-long; Yu Ping; Luo Jie; Song Xiu-yun 📂 Article 📅 2004 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 520 KB

Treatment Rationale Study Design for the

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

✍ David R. Spigel; Martin J. Edelman; Tony Mok; Kenneth O'Byrne; Luis Paz-Ares; We 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 255 KB